Laffer Tengler Investments Inc. Purchases 237 Shares of UnitedHealth Group Incorporated $UNH

Laffer Tengler Investments Inc. raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 46.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 742 shares of the healthcare conglomerate’s stock after purchasing an additional 237 shares during the quarter. Laffer Tengler Investments Inc.’s holdings in UnitedHealth Group were worth $231,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Vise Technologies Inc. purchased a new position in UnitedHealth Group in the 2nd quarter valued at approximately $7,164,000. Alpha Cubed Investments LLC boosted its holdings in shares of UnitedHealth Group by 16.2% in the second quarter. Alpha Cubed Investments LLC now owns 35,577 shares of the healthcare conglomerate’s stock worth $11,099,000 after acquiring an additional 4,953 shares during the period. Allworth Financial LP raised its stake in shares of UnitedHealth Group by 18.0% during the 2nd quarter. Allworth Financial LP now owns 90,883 shares of the healthcare conglomerate’s stock valued at $28,353,000 after purchasing an additional 13,838 shares during the period. Illinois Municipal Retirement Fund boosted its stake in UnitedHealth Group by 1.9% in the 2nd quarter. Illinois Municipal Retirement Fund now owns 59,185 shares of the healthcare conglomerate’s stock worth $18,464,000 after purchasing an additional 1,092 shares during the period. Finally, ProShare Advisors LLC increased its position in shares of UnitedHealth Group by 5.1% during the second quarter. ProShare Advisors LLC now owns 279,291 shares of the healthcare conglomerate’s stock valued at $87,130,000 after buying an additional 13,538 shares during the period. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on UNH. Zacks Research raised shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. UBS Group boosted their price target on shares of UnitedHealth Group from $378.00 to $430.00 and gave the company a “buy” rating in a research report on Wednesday, October 29th. Mizuho increased their price objective on UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a research report on Thursday, October 9th. TD Cowen upped their target price on UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a research note on Thursday, October 30th. Finally, Oppenheimer dropped their price target on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Eighteen investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $397.12.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $324.29 on Monday. The stock has a market cap of $293.75 billion, a price-to-earnings ratio of 16.93, a P/E/G ratio of 2.28 and a beta of 0.47. The stock’s 50-day moving average is $345.84 and its 200 day moving average is $321.90. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. During the same period last year, the firm posted $7.15 earnings per share. The business’s revenue was up 12.2% compared to the same quarter last year. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.